Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections
Altea Gallerani(Azienda Ospedaliero-Universitaria di Modena), Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Milo Gatti(University of Bologna), Erica Franceschini(University of Modena and Reggio Emilia), Nicole Barp(Azienda Ospedaliero-Universitaria di Modena), Federico Pea(University of Bologna), Gabriella Orlando(University of Modena and Reggio Emilia), Sara Volpi(University of Modena and Reggio Emilia), Cristina Mussini(University of Modena and Reggio Emilia), Cinzia Puzzolante(University of Modena and Reggio Emilia), Alessandra Soffritti(Azienda Ospedaliero-Universitaria di Modena), Antonella Santoro(University of Modena and Reggio Emilia), Stefania Casolari(Azienda Ospedaliero-Universitaria di Modena), Andrea Bedini(Azienda Ospedaliero-Universitaria di Modena), Marianna Menozzi(Azienda Ospedaliero-Universitaria di Modena)
Cited by 25
Related Papers
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424